Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

The goal of this observational study is to evaluate the feasibility and acceptability of a newly developed digital education and self-management program for people with fibrotic interstitial lung diseases (FILD) during inpatient pulmonary rehabilitation and outpatient interstitial lung disease (ILD) care. The study also explores whether participation in the program is associated with changes in health-related outcomes.

The main questions this study aims to answer are:

* Is the digital education and self-management program acceptable, useful, and practical for patients with FILD? * Is it feasible to recruit and retain patients and to collect outcome data for a future larger effectiveness study? * Do patients who participate in the program show differences in health-related outcomes compared with patients treated before the program was implemented?

Patients who consent to participate during the implementation phase will be offered access to the digital education and self-management program. Their outcomes will be compared with those of a historical cohort of patients who received usual care before the program was introduced.

Participants will:

* Use a web-based digital education and self-management program with multiple e-learning modules tailored to individual needs and preferences * Access the program via smartphone, tablet, or computer during inpatient rehabilitation or outpatient care * Discuss questions related to the program content with healthcare professionals during routine rehabilitation sessions or clinic visits * Complete questionnaires about their experience with the program and their health-related outcomes

Eligibility criteria

Qualifiers

Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only)

Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB_2016-01524) and agreed to further use of data for further research purpose (for Inselspital only)

Age ≥ 18 years

Written informed consent

Disqualifiers

Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures

Sarcoidosis

Trial design

Treatments tested in this trial

  • Blended patient education and self-management programme

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators

Insel Gruppe AG, University Hospital Bern

Lead sponsor

University of Zurich

Collaborator

ZHAW School of Health Professions, Institute of Physiotherapy

Collaborator